共 50 条
- [1] Efficacy and safety of once-weekly bortezomib in multiple myeloma patients [J]. BLOOD, 2010, 116 (23) : 4745 - 4753
- [2] Efficacy and safety of bortezomib in once weekly vs. twice weekly dosing in the treatment of multiple myeloma [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S152 - S152
- [5] Efficacy and safety of a modified daratumumab/bortezomib/dexamethasone regimen using once weekly bortezomib in relapsed refractory multiple myeloma [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E150 - E151
- [6] EFFICACY AND SAFETY OF WEEKLY INFUSION BORTEZOMIB IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 149 - 149
- [7] Efficacy and Safety of Weekly Bortezomib Containing VMP Followed By Bortezomib Maintenance Therapy in Unfit or Frail Multiple Myeloma Patients [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E142 - E143
- [9] Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis [J]. PLOS ONE, 2017, 12 (03):